Get Unlimited Plan at 75% OFF!

Advertisement
logo

IOL Chemicals & Pharmaceuticals

IOLCP
Small Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement

IOL Chemicals & Pharmaceuticals Share price and Fundamental Analysis

View All Details
View All Details
IOL Chemicals and Pharmaceuticals Ltd is a leading organic chemicals manufacturer and supplier in India. The company manufactures active pharmaceutical ingredient, organic chemicals and intermediates. The company was incorporated in the year 1986.
Company Incorporation1986
ChairmanRajender Mohan Malla
Head QuartersLudhiana
Previous NameNA

Key Metrics

Market Cap (Cr)
1,898.54
PE Ratio
19.54
Industry P/E
35.07
PEG Ratio
0.11
ROE
6.02%
ROCE
8.32%
ROA
4.29%
Total Debt (Cr)
128.42
Debt to Equity
0.08
Dividend Yield
1.55%
EPS
3.31
Book Value & P/B
56.53 x 1.14
Face Value
2
Outstanding Shares(Cr)
29.35
Current Ratio
2.71
EV to Sales
0.91

Stock Returns

1 Week-0.86%
1 Month+4.77%
6 Months-16.2%
1 Year-14.87%
3 Years-22.93%
5 Years+9.73%

CAGR

1 Year CAGR

Revenue Growth

-3.8%

Net Profit Growth

-3.39%

Operating Profit Growth

+3.73%

Dividend Growth

+25%

Stock Returns CAGR

-17.42%
no_data

No Stocks

Smart Score

1.8
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

/ View Standalone

Profit and Loss Statement

/ View Standalone
Credit Rating
Director Report
Chairman Report
Auditor Report

Balance sheet

/ View Standalone

Cashflow Statement

/ View Standalone

Promoters : 0.00%

FIIs : 0.00%

DIIs : 0.00%

Public : 0.00%

Promoter
FII/FPI
DII
Public

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

IOL Chemicals & Pharmaceuticals Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

IOL Chemicals & Pharmaceuticals Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

IOL Chemicals and Pharmaceuticals Ltd is a leading organic chemicals manufacturer and supplier in India. The company manufactures active pharmaceutical ingredient, organic chemicals and intermediates. The company was incorporated in the year 1986.

The company manufactures and supplies industrial chemicals and bulk drugs for use in various pharmaceutical applications. Their portfolio includes industrial chemicals, industrial organic chemicals and bulk drugs.

The company has two segments namely chemicals and pharmaceuticals. Under the chemical division, the company manufactures bulk chemicals, such as acetic acid and specialty chemicals, including ethyl acetate and acetic anhydride. Under pharmaceuticals division, the company manufactures active pharmaceutical ingredient, Ibuprofen.

The company has two manufacturing units namely API Unit and Chemical Unit located in Punjab. API Unit manufactures Ibuprofen with the installed Capacity of 10 MTPD. Chemical Unit manufactures organic chemicals such as Glacial Acetic Acid, Ethyl Acetate, Acetic Anhydride, Mono chloro acetic Acid, Acetyl Chloride and Iso butyl Benzene.

The company is having their presence in over 40 countries across the world, which includes Bangladesh, Thailand, UAE, Syria, Singapore, Hong Kong, Pakistan, Egypt, and many others. They have strong business relationships with a number of prestigious clients such as Ranbaxy Labs, Dr Reddy. DS Group, Cipla, Uflex Industries, ITC Ltd, ICI Paints, Asian Paints, Pidillte, Rallis India, Hindustan Polymide, Gujarat Super Phosphate and Avon Organics Ltd etc.

The capacity enhancement project and Multi Product PPIs Plant and other pharmaceutical intermediate products with a CAPEX of Rs 130 crore was completed in 2012. The Company undertook another project of multi product plant for manufacture active pharmaceutical ingredients and upgrading of R&D facilities involving a CAPEX of Rs 58.41 crore.

G Drugs and Pharmaceuticals Limited (GDPL) was merged with Company, through The Board for Industrial and Financial Reconstruction (BIFR), vide its order dated 15 March 2012, with appointed date of 1 April 2010. The said Merger was made effective on 20 April 2012 and consequently GDPL ceased to exit from that date.

During the current year 2016-17, the Company converted its existing multiple purpose plant into a dedicated ibuprofen manufacturing facility and resulting to its conversion, the ibuprofen manufacturing facility increased from 6200 TPA to 7200 TPA. During year 2017-18, Unit III to manufacture Fenofi brate, Clopidogrel and Lamotrigine Project was set up which costed Rs 16.48 crore. The company also setup Unit IV for manufacturing Metformin an anti-diabetic drug with a capacity of 3000 MT per annum with project cost of Rs 10.02 crore. It enhanced installed capacity of Ibuprofen from 7200 TPA to 10000 TPA by debottlenecking and re-engineering the plant in the month of August 2018.

During year 2019, the Company has enhanced installed capacity of Metformin from 3,000 TPA to 4,000 TPA with a capex of Rs 2.71 crore; it set up Unit V o manufacture Clopidogrel Bisulphate & Fenofibrate with a capacity of 180 MT per annum with capex of Rs 19.26 crore; it further enhanced existing manufacturing facilities of Ibuprofen from 10,000 TPA to 12,000 TPA and Iso Butyl Benzene from 9,000 TPA to 12,000 TPA in May 2019 with capex of Rs 12.10 crore. During 2020, the Company set up 'Unit VI', with an installed capacity of 240 MT per annum, which costed Rs 33.83 Crore, to manufacture 'Pantoprazole' and has started its trial production. During 2021, the Company set up an another Unit-7 for manufacturing Metformin with an additional capacity of 7,200 MT per annum for project costing Rs 28 cr. It installed new manufacturing facilities 'Unit-8' to manufacture Ibuprofen Derivatives and other Pharma Products during FY 2020-21. It increased existing manufacturing facilities of Ethyl Acetate from 87,000 MT per annum to 100,000 MT per annum in Chemical segment during 2021-22.

During the year 2022-23, IOL- Foundation was incorporated as wholly owned subsidiary company. The Company set up multi product manufacturing facilities Unit 10' for manufacturing pharma APIs. It identified to manufacture Fenofibrate, Lamotrigine etc in this unit. Further, it also initiated the project for installation of new manufacturing facilities (Unit-9) for manufacturing Gabapentin and other Pharma products during the year, which is under implementation.

IOL Chemicals & Pharmaceuticals Share Price

IOL Chemicals & Pharmaceuticals share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

IOL Chemicals & Pharmaceuticals Market Cap

Market capitalization of IOL Chemicals & Pharmaceuticals indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how IOL Chemicals & Pharmaceuticals is valued compared to its competitors.

IOL Chemicals & Pharmaceuticals PE Ratio

IOL Chemicals & Pharmaceuticals PE ratio helps investors understand what is the market value of each stock compared to IOL Chemicals & Pharmaceuticals 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

IOL Chemicals & Pharmaceuticals PEG Ratio

The PEG ratio of IOL Chemicals & Pharmaceuticals evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

IOL Chemicals & Pharmaceuticals ROE (Return on Equity)

Return on Equity (ROE) measures how effectively IOL Chemicals & Pharmaceuticals generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

IOL Chemicals & Pharmaceuticals ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of IOL Chemicals & Pharmaceuticals in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

IOL Chemicals & Pharmaceuticals Total Debt

Total debt of IOL Chemicals & Pharmaceuticals shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

IOL Chemicals & Pharmaceuticals Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of IOL Chemicals & Pharmaceuticals compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

IOL Chemicals & Pharmaceuticals CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of IOL Chemicals & Pharmaceuticals over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

IOL Chemicals & Pharmaceuticals Technical Analysis

Technical analysis of IOL Chemicals & Pharmaceuticals helps investors get an insight into when they can enter or exit the stock. Key components of IOL Chemicals & Pharmaceuticals Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where IOL Chemicals & Pharmaceuticals shares often struggle to rise above due to selling pressure.

IOL Chemicals & Pharmaceuticals Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect IOL Chemicals & Pharmaceuticals ’s financial health and profitability.

IOL Chemicals & Pharmaceuticals Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

IOL Chemicals & Pharmaceuticals Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

IOL Chemicals & Pharmaceuticals Financials

The financials of IOL Chemicals & Pharmaceuticals provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

IOL Chemicals & Pharmaceuticals Profit and Loss Statements

The profit and loss statement of IOL Chemicals & Pharmaceuticals highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of IOL Chemicals & Pharmaceuticals .

IOL Chemicals & Pharmaceuticals Balance Sheet

The balance sheet presents a snapshot of IOL Chemicals & Pharmaceuticals ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

IOL Chemicals & Pharmaceuticals Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App